Glide Pharma is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of biological medicines such as proteins and vaccines based on its proprietary Glide SDI™ - the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments. The Glide SDI™ is simple, clean and easy to use, even at home, bringing injection technology into the 21st century.

Glide Pharma has been assessed and certified as meeting the requirements of ISO 13485:2003

Please contact Glide Pharma for Alliance and Partnering opportunities

Register to receive Glide Pharma e-mail alerts on press releases, updates and newsletters by e-mail.

 

 

 

 

See a demo of the Glide technology in action

Latest News

Glide and Lipoxen to collaborate on diabetes drug Glide Pharma secures further £2.2 million to accelerate development programme Glide Pharma secures two more pharma partners Reach MD radio interview with Charles Potter Glide Pharma signs biologicals deal with major pharma company Where to meet us